FDA Approved: FIRAZYR — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approves a supplemental application for FIRAZYR (icatibant acetate) from Takeda Pharmaceuticals America, expanding/updating its approved labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Firazyr (icatibant)

Snippet

SUPPL AP for FIRAZYR (ICATIBANT ACETATE)